Advertisement

Picture EBD Group BioTech Showcase 2022 Present Your Innovations 650x100

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from the Benelux countries Belgium, Luxembourg and The Netherlands or involving organisations from these countries.

Total search results: 1387 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Rockefeller Univ–Lumicks: microscope, 202201 supply of Quadrupole C-Trap system to lab of Prof Michael O’Donnell 2022-01-12
Creoptix–Spectris: investment, 202201 acquisition of Creoptix AG by Malvern Panalytical 2022-01-11
Antigon–Analis: investment, 202112 financing round totalling €1.5m incl new investor Analis SA 2021-12-22
Antigon–BeAngels: investment, 202112 financing round totalling €1.5m incl existing investor Be Angels 2021-12-22
Antigon–HTP Europe: investment, 202112 financing round totalling €1.5m incl new investor HTP Europe 2021-12-22
Antigon–Sambrinvest: investment, 202112 financing round totalling €1.5m incl existing investor Sambrinvest 2021-12-22
Antigon–SEVERAL: investment, 202112 financing round €1.5m with Sambrinvest + BeAngels + Analis + HTP Europe 2021-12-22
Alesta Therapeutics–Thuja Capital: investment, 202112 existent investment of Thuja Capital Healthcare Fund III 2021-12-21
EsoBiotec–Thuja Capital: investment, 202112 existent investment of Thuja Capital Healthcare Fund III 2021-12-21
Thuja Capital–SEVERAL: investment, 202112 final closing of Thuja Capital Heathcare Fund III at €76m incl investor EIF 2021-12-21
NorthSea Therapeutics–BioGeneration Ventures: investment, 202112 financing round Series C totalling $80m incl existing + co-investor BGV 2021-12-17
NorthSea Therapeutics–Forbion: investment, 202112 financing round Series C totalling $80m incl existing + co-lead investor Forbion 2021-12-17
NorthSea Therapeutics–Hercules Capital: investment, 202112 financing round Series C totalling $80m incl new + co-investor Hercules Capital 2021-12-17
NorthSea Therapeutics–New Science Ventures: investment, 202112 financing round Series C totalling $80m incl existing + co-investor New Science 2021-12-17
NorthSea Therapeutics–Novo Group: investment, 202112 financing round Series C totalling $80m incl existing + co-investor Novo Seeds 2021-12-17
NorthSea Therapeutics–OTHER: investment, 202112 financing round Series C totalling $80m incl new + co-investor large managed care organisation 2021-12-17
NorthSea Therapeutics–SEVERAL: investment, 202112 financing round Series C $80m co-led by Ysios Capital + Forbion Growth 2021-12-17
NorthSea Therapeutics–Sofinnova: investment, 202112 financing round Series C totalling $80m incl existing + co-investor Sofinnova 2021-12-17
NorthSea Therapeutics–VenBio: investment, 202112 financing round Series C totalling $80m incl existing + co-investor VenBio 2021-12-17
NorthSea Therapeutics–Ysios Capital: investment, 202112 financing round Series C totalling $80m incl new + co-lead investor Ysios Capital 2021-12-17
Anaveon–Forbion: investment, 202112 financing round Series B totalling CHF110m incl new + lead investor Forbion 2021-12-16
Anaveon–SEVERAL: investment, 202112 financing round Series B CHF110m with new + lead investor Forbion 2021-12-16
Argobio–GeneCode: GDNF mimetics, 202112– collab development with up to €3m funding for incubation phase by Argobio to incorporate new biotech company 2021-12-16
Bioqube Ventures–Metrion Biosciences: drug discovery services, 202112– collab project to identify ion channel inhibtors for autoimmune diseases 2021-12-16
Bioqube Ventures–Optimum Strategic Communications: public relations, 202112 service existent by Optimum 2021-12-16
Synerkine Pharma–Flerie Invest: investment, 202112 financing round Series A extension totalling €3.5m incl new + lead investor Flerie Invest 2021-12-16
Synerkine Pharma–SEVERAL: investment, 202112 financing round Series A extension €3.5m from Flerie Invest + Thuja Capital + Utrecht Holdings 2021-12-16
Synerkine Pharma–Thuja Capital: investment, 202112 financing round Series A extension totalling €3.5m incl existing + co-investor Thuja Capital 2021-12-16
Synerkine Pharma–Univ Utrecht: investment, 202112 financing round Series A extension totalling €3.5m incl existing + co-investor Utrecht Holdings 2021-12-16
Biogazelle–CellCarta: investment, 202112 acquisition of Biogazelle by CellCarta 2021-12-14
BMS–Immatics: TCR Bispecific, 202112– license ww excl $150m upfront + $770m milestones + royalties to IMA401 programme 2021-12-14
Sirius Medical–SEVERAL: investment, 202112 financing round Series A 2nd closing €na with BOM Brabant Ventures + Holland Capital et al 2021-12-14
Corteria Pharmaceuticals–SEVERAL: investment, 202112 seed financing round €12m led by Kurma Partners 2021-12-09
Corteria Pharmaceuticals–V-Bio Ventures: investment, 202112 seed financing round totalling €12m incl co-investor V-Bio Ventures 2021-12-09
Forbion European Acquisition Corporation–SEVERAL: investment, 202112 SPAC US IPO $110m with 11m units at $10/unit 2021-12-09
Merck (DE)–Merck (DE): investment, 202112 third increase of financial commitment by €600m in evergreen corporate venture fund M Ventures 2021-12-08
HypnoVR–SEVERAL: investment, 202112 financing round Series A €4.5m led by Theodorus 2021-12-07
HypnoVR–Theodorus: investment, 202112 financing round Series A totalling €4.5m incl new + lead investor Theodorus 2021-12-07
AviadoBio–SEVERAL: investment, 202112 financing round Series A £58.6m led by NEA + co-led by Monograph Capital 2021-12-03
Novartis–UCB: Parkinson drugs, 202112– collab up to $1.5b with $150m upfront ww developm + commercialisation of UCB0599 + option for UCB7853 2021-12-02
Sotio–PPF Group: investment, 202112 new €280m funding for Sotio Biotech from owner PPF Group 2021-12-02
Amarna Therapeutics–C4 Holding: investment, 202112 financing round totalling €4m incl existing investor C4 Holding BV 2021-12-01
Amarna Therapeutics–Flerie Invest: investment, 202112 financing round totalling €4m incl existing investor Flerie Invest AB 2021-12-01
Amarna Therapeutics–Netherlands (govt): credit, 202112 innovation credit €1m from RVO 2021-12-01
Amarna Therapeutics–SEVERAL: investment, 202112 financing round €4m from existing investors C4 Holding BV + Flerie Invest AB 2021-12-01
HotSpot Therapeutics–Life Sciences Partners: investment, 202111 financing round Series C totalling $100m incl new + significant co-investor LSP 2021-11-29
HotSpot Therapeutics–SEVERAL: investment, 202111 financing round Series C $100m led by Pivotal BioVenture Partners 2021-11-29
Molecubes–Bruker: investment, 202111 acquisition €na by Bruker 2021-11-19
PPF Group–LegoChem: ADC technology, 202111– excl target-specific collab + license agreem up to $1.03b with up to $29.5m near-term for 5 Sotio programs 2021-11-16
Life Sciences Partners–EQT: investment, 202111– acquisition €450m upfront with €112.5m in cash + €337.5m in shares plus €25m milestone ANNOUNCED 2021-11-10
Life Sciences Partners–SEVERAL: investment, 202111 announced LSP 7 fund with €850m incl EIF with expected final closing at €1b 2021-11-04
Mainz Biomed–SEVERAL: investment, 202111 IPO $10m with 2m common shares at $5/share at Nasdaq Capital Market 2021-11-04
Amarna Therapeutics–Droege Investment: biologics contract manufacturing, 202111c supply production of AMA005 for clinical trials by Halix 2021-11-01
MDxHealth–SEVERAL: investment, 202110–202111 US IPO $45m+$6.75m of ADSs (each 10 shares) at $12/ADS US listing at Nasdaq Capital Market 2021-10-28
Origo Biopharma–Agomab Therapeutics: investment, 202110– acquisition €na by Agomab ANNOUNCED 2021-10-28
Pan Cancer T–Akampion: public relations, 202111 service existent by Akampion 2021-10-28
Pan Cancer T–Erasmus Univ: investment, 202110 existent founding investor Erasmus MC 2021-10-28
Pan Cancer T–SEVERAL: investment, 202110 seed financing round expansion €na from new investor Thuja Capital + existing investors 2021-10-28
Pan Cancer T–Thuja Capital: investment, 202110 seed financing round expansion totalling €na incl new investor Thuja Capital 2021-10-28
Noxxon–LifeSci: public relations, 202110 service existent LifeSci Advisors is investor/media relations contact 2021-10-27
DNA Script–Life Sciences Partners: investment, 202110 financing round Series C totalling $165m incl existing + co-investor LSP 2021-10-26
DNA Script–SEVERAL: investment, 202110 financing round Series C $165m co-led by Coatue Management + Catalio Capital Management 2021-10-26
TrueMass–Scott Partnership: public relations, 202110 service existent by Scott PR 2021-10-26
Egle Therapeutics–SEVERAL: investment, 202110 financing round Series A €40m co-led by LSP + InnoBio 2 Fund of Bpifrance 2021-10-22
Rectify Pharmaceuticals–Forbion: investment, 202110 financing round Series A totalling $100m incl co-lead investor Forbion 2021-10-14
Rectify Pharmaceuticals–SEVERAL: investment, 202110 financing round Series A $100m co-led by Atlas Venture + Omega Funds + Forbion + Longwood Fund 2021-10-14
Atbtherapeutics–Trophic Communications: public relations, 202110 service existent by Trophic Communications 2021-10-05
iOmx Therapeutics–SEVERAL: investment, 202110 financing round Series B €65m co-led by Athos Service GmbH + MIG Capital AG 2021-10-05
Biotalys–Consilium: public relations, 202109 service existent by Consilium Strategic Communications 2021-09-30
Univ Aarhus–Novo Group: grant, 202109–202808 grant DKK630m (€84.7m) to establish NNF CO2 Research Center at AU + six satellite institutes 2021-09-22
Anjarium Biosciences–Abingworth: investment, 202109 financing round Series A totalling CHF55.5m incl co-lead investor Abingworth 2021-09-16
Anjarium Biosciences–Gimv: investment, 202109 financing round Series A totalling CHF55.5m incl co-lead investor Gimv 2021-09-16
Anjarium Biosciences–SEVERAL: investment, 202109 financing round Series A CHF55.5m ($61m) co-led by Abingworth + Gimv 2021-09-16
Meatable–DSM: cell culture media, 202109– collab developm growth media for cultivated meat 2021-09-13
Cardior Pharmaceuticals–ABP (NL): investment, 202108 financing round Series B totalling €64m incl new + lead investor Inkef Capital 2021-08-25
Cardior Pharmaceuticals–Fund+: investment, 202108 financing round Series B totalling €64m incl new + co-investor Fund+ 2021-08-25
Cardior Pharmaceuticals–SEVERAL: investment, 202108 financing round Series B €64m led by new investor Inkef Capital 2021-08-25
OncXerna Therapeutics–Qiagen: molecular companion diagnostics, 202108– collab developm Xerna TME panel as NGS CDx for navicixizumab 2021-08-09
Qiagen–OncXerna Therapeutics: molecular companion diagnostics, 202108– license non-excl to Xerna TME panel as NGS CDx for Qiagen 2021-08-09
Mestag Therapeutics–Forbion: investment, 202108 seed financing round extension totalling $34m incl new + lead investor Forbion 2021-08-03
Mestag Therapeutics–SEVERAL: investment, 202108 seed financing round extension $34m led by Forbion bringing total seed round to $45m 2021-08-03
Spectricity–SEVERAL: investment, 202108 financing round Series B €14m 2021-08-03
T-Knife–SEVERAL: investment, 202108 financing round Series B $110m led by new investor Fidelity Management and Research 2021-08-02
Topas Therapeutics–Gimv: investment, 202107 financing round Series B extension €18m incl existing investor Gimv 2021-07-29
Topas Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €18m bringing total round to €40m incl all existing investors 2021-07-29
Topas Therapeutics–Vesalius Biocapital: investment, 202107 financing round Series B extension €18m incl existing investor Vesalius Biocapital III 2021-07-29
Artios Pharma–SEVERAL: investment, 202107 financing round Series C £110m ($153m) co-led by Omega Funds + TCG X 2021-07-27
Axa–SEVERAL: investment, 202107 raising of €1.9b equity by AXA IM Alts to invest in European Life Sciences primarily via Kadans Science Partner 2021-07-26
Slingshot Biosciences–Anterra Capital: investment, 202107 financing round Series A totalling $23m inc co-investor Anterra Capital 2021-07-22
Slingshot Biosciences–SEVERAL: investment, 202107 financing round Series A $23m led by Northpond Ventures with ARCH Venture Partners + Anterra Capital 2021-07-22
Coave Therapeutics–Fund+: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Fund+ 2021-07-21
Coave Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €21.2m bringing total Series B to €33.1m 2021-07-21
Coave Therapeutics–V-Bio Ventures: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor V-Bio Ventures 2021-07-21
NanoSyrinx–Merck (DE): investment, 202107 seed financing round totalling £6.2m incl existing + co-lead investor M Ventures 2021-07-19
NanoSyrinx–SEVERAL: investment, 202107 seed financing round £6.2m co-led by Octopus Ventures + M Ventures 2021-07-19
Nerre Therapeutics–Forbion: investment, 202107 financing round Series B2 totalling £20m incl existing + co-investor Forbion Capital Partners 2021-07-07
Nerre Therapeutics–SEVERAL: investment, 202107 financing round Series B2 £20m led by Columbus Venture Partners 2021-07-07
Promethera–SEVERAL: investment, 202106– financing round €20m incl €10m from Shang Ying Intl Holdings Ltd (HK) 2021-06-30
RheinCell Therapeutics–Catalent: investment, 202106– acquisition of RheinCell by Catalent ANNOUNCED 2021-06-24
Corlieve Therapeutics–Uniqure: investment, 202106–202107 acquisition €46.3m upfront cash + €203.7m milestones 2021-06-22
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Fighting Customers 650x100px

» top